Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus

Abstract

Mycophenolate mofetil (MMF) has been increasingly used in patients with systemic lupus erythematosus (SLE). While most information concentrates on lupus nephritis, its efficacy in nonrenal manifestations of SLE has not been systematically studied. We describe the successful use of MMF in a patient with SLE-related hemolytic anemia that was refractory to cyclophosphamide, pulse methylprednisolone, intravenous immunoglobulin and cyclosporine. The mechanisms of action of MMF are briefly reviewed.

Keywords

haemolysis haematological mycophenolic acid immunosuppressive transplant

Get full access to this article

View all access options for this article.

References

Mok CC , Lee KW , Ho CTK et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population . Rheumatology (Oxford) 2000; 39: 399-406 .

Massardo L , Martinez M , Jacobelli S. Survival of Chilean patients with systemic lupus erythematosus . Semin Arthritis Rheum 1994; 24: 1-11 .

Kokori SI , Ioannidis JP , Voulgarelis M et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus . Am J Med 2000; 108: 198-204 .

Abu-Shakra M , Shoenfeld Y. Azathioprine therapy for patients with systemic lupus erythematosus . Lupus 2001; 10: 152-153 .

Asano Y , Maeda M , Uchida N et al. Immunosuppressive therapy for patients with refractory anemia . Ann Hematol 2001; 80: 634-638 .

Flores G , Cunningham-Rundles C , Newland AC et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients . Am J Hematol 1993; 44: 237-242 .

Perrotta S , Locatelli F , La Manna A et al. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus . Br J Haematol 2002; 116: 465-467 .

Mok CC , Lai KN. Mycophenolate mofetil in lupus nephritis . Am J Kidney Dis 2002; 40: 447-457 .

Avina-Zubieta JA , Galindo-Rodriguez G , Robledo I et al. Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus . Lupus 2003; 12: 52-57 .

10.

Rivero SJ , Alger M , Alarcon-Segovia D. Splenectomy for hemocytopenia in systemic lupus erythematosus. A controlled appraisal . Arch Intern Med 1979; 139: 773-776 .

11.

Zimmer-Molsberger B , Knauf W , Thiel E. Mycophenolate mofetil for severe autoimmune haemolytic anaemia . Lancet 1997; 350: 1003-1004 .

12.

Howard J , Hoffbrand AV , Prentice HG et al. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura . Br J Haematol 2002; 117: 712-715 .

13.

Chan TM , Li FK , Tang CS et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group . N Engl J Med 2000; 343: 1156-1162 .

14.

Kapitsinou PP , Boletis JN , Skopouli FN , Boki KA , Moutsopoulos HM. Lupus nephritis: treatment with mycophenolate mofetil . Rheumatology (Oxford) 2004; 43: 377-380 .

15.

Alba P , Karim MY , Hunt BJ et al. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome . Lupus 2003; 12: 633-635 .

16.

Vasoo S , Thumboo J , Fong KY. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil . Lupus 2003; 12: 630-632 .

17.

Karim MY , Alba P , Cuadrado MJ et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents . Rheumatology (Oxford) 2002; 41: 876-882 .

18.

Riskalla MM , Somers EC , Fatica RA , McCune WJ. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus . J Rheumatol 2003; 30: 1508-1512 .

19.

Fossati-Jimack L , Ioan-Facsinay A , Reininger L et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III . J Exp Med 2000; 191: 1293-1302 .

20.

Jonsson CA , Carlsten H. Mycophenolic acid inhibits inosine 50-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells . Int Immunopharmacol 2003; 3: 31-37 .

21.

Ramos MA , Pinera C , Setien MA et al. Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice . Nephrol Dial Transplant 2003; 18: 878-883 .